278 related articles for article (PubMed ID: 11027273)
1. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.
Smith JL; Schaffner AE; Hofmeister JK; Hartman M; Wei G; Forsthoefel D; Hume DA; Ostrowski MC
Mol Cell Biol; 2000 Nov; 20(21):8026-34. PubMed ID: 11027273
[TBL] [Abstract][Full Text] [Related]
2. Persistent activation of mitogen-activated protein kinases p42 and p44 and ets-2 phosphorylation in response to colony-stimulating factor 1/c-fms signaling.
Fowles LF; Martin ML; Nelsen L; Stacey KJ; Redd D; Clark YM; Nagamine Y; McMahon M; Hume DA; Ostrowski MC
Mol Cell Biol; 1998 Sep; 18(9):5148-56. PubMed ID: 9710599
[TBL] [Abstract][Full Text] [Related]
3. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling.
Chandrasekar B; Mummidi S; Valente AJ; Patel DN; Bailey SR; Freeman GL; Hatano M; Tokuhisa T; Jensen LE
J Biol Chem; 2005 Jul; 280(28):26263-77. PubMed ID: 15890643
[TBL] [Abstract][Full Text] [Related]
4. Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation.
Park HS; Kim MS; Huh SH; Park J; Chung J; Kang SS; Choi EJ
J Biol Chem; 2002 Jan; 277(4):2573-8. PubMed ID: 11707464
[TBL] [Abstract][Full Text] [Related]
5. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
6. TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway.
Nguyen MH; Ho JM; Beattie BK; Barber DL
J Biol Chem; 2001 Aug; 276(35):32704-13. PubMed ID: 11435425
[TBL] [Abstract][Full Text] [Related]
7. Downstream effectors of oncogenic ras in multiple myeloma cells.
Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling.
Ivanov VN; Krasilnikov M; Ronai Z
J Biol Chem; 2002 Feb; 277(7):4932-44. PubMed ID: 11733515
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway.
Hundal RS; Salh BS; Schrader JW; Gómez-Muñoz A; Duronio V; Steinbrecher UP
J Lipid Res; 2001 Sep; 42(9):1483-91. PubMed ID: 11518769
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF
Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.
Kirito K; Watanabe T; Sawada K; Endo H; Ozawa K; Komatsu N
J Biol Chem; 2002 Mar; 277(10):8329-37. PubMed ID: 11756417
[TBL] [Abstract][Full Text] [Related]
12. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways.
Huang HM; Huang CJ; Yen JJ
Blood; 2000 Sep; 96(5):1764-71. PubMed ID: 10961875
[TBL] [Abstract][Full Text] [Related]
13. Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells.
Zhao Y; You H; Yang Y; Wei L; Zhang X; Yao L; Fan D; Yu Q
J Cell Biochem; 2004 Feb; 91(3):621-32. PubMed ID: 14755690
[TBL] [Abstract][Full Text] [Related]
14. Impairment of macrophage survival by NaCl: implications for early pulmonary inflammation in cystic fibrosis.
Kerby GS; Cottin V; Accurso FJ; Hoffmann F; Chan ED; Fadok VA; Riches DW
Am J Physiol Lung Cell Mol Physiol; 2002 Jul; 283(1):L188-97. PubMed ID: 12060576
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant.
Chian R; Young S; Danilkovitch-Miagkova A; Rönnstrand L; Leonard E; Ferrao P; Ashman L; Linnekin D
Blood; 2001 Sep; 98(5):1365-73. PubMed ID: 11520784
[TBL] [Abstract][Full Text] [Related]
16. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
[TBL] [Abstract][Full Text] [Related]
17. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
[TBL] [Abstract][Full Text] [Related]
19. Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression.
Nguyen H; Ramana CV; Bayes J; Stark GR
J Biol Chem; 2001 Sep; 276(36):33361-8. PubMed ID: 11438544
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1.
Maundrell K; Antonsson B; Magnenat E; Camps M; Muda M; Chabert C; Gillieron C; Boschert U; Vial-Knecht E; Martinou JC; Arkinstall S
J Biol Chem; 1997 Oct; 272(40):25238-42. PubMed ID: 9312139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
